Khalid M. Khan
9Patents
1h-index
36Co-inventors
47Inventor score
Filing activity: Sep 7, 2010 → Jun 29, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9387198B1 | Inhibitors of advanced glycation end-products (ages)formation | Human Necessities | 1 | Active |
| US9643169B1 | Process for the preparation of quinoline based ionic fluoride salts (QUFS) | Performing Operations; Transporting | 1 | Active |
| US10183000B1 | 2, 4-dinitroanilino-benzoic acid: novel insulinotropic agent for the treatment of diabetes | Human Necessities | 0 | Active |
| US8148368B2 | 7-nitro-2-(3-nitro phenyl)-4H-3,1-benzoxazin-4-one or derivatives thereof for treating or preventing antiviral infections | Human Necessities | 0 | Active |
| US9447057B2 | Schiff bases of thiazoles: a new class of ureases inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9387186B2 | Thiourea derivatives | Human Necessities | 0 | Active |
| US11654132B2 | Methods for treating COVID-19 | Chemistry; Metallurgy | 0 | Active |
| US8809354B2 | 3-amino-2-(4-nitrophenyl)-4-(3H)-quinazolinone or derivatives thereof for treating or preventing antiviral infections | Human Necessities | 0 | Active |
| US9119857B2 | Small molecule activators of HsIV protease for development of novel antimicrobials | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.